PJP Invesco Dynamic Pharmaceuticals ETF
Dynamic Pharmaceutical Intellidex TR USD

NAV as of 25-Nov-2022

78.6400

4 Week: 75.94 - 78.59

52 Week: 69.08 - 83.54

Latest Closing Price

78.59

Premium / Discount

0.07

Expense Ratio

0.56%

Investment Objective

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
Invesco
Asset Under Management:
326,593,372
Launch Date:
22/06/2005
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
30
Trading Currency:
USD
Style:
Mid Value
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-3.131.27-2.47
1 Day0.540.000.00
1 Week0.371.300.29
1 Month4.305.190.83
3 Months4.9311.360.43
6 Months4.7215.130.31
1 Year-1.7419.56-0.09
2 Years17.6323.850.74
3 Years24.6738.530.64
5 Years25.3946.280.55
10 Years127.8762.802.04

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 24.729355.600328.104611.0523-19.249615.3146-1.69994.678011.175114.4475
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 24.000020.000041.000026.000088.000086.000067.0000100.000091.000033.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
15/12/201629/12/20160.2074
16/06/201629/06/20160.1794
23/12/201430/12/20141.6507
18/12/201430/12/20140.0910
18/09/201430/10/20140.0824
19/06/201429/06/20140.1449
19/12/201330/12/20130.0650
19/09/201329/09/20130.0418
20/06/201327/06/20130.1187
14/03/201327/03/20130.0100

Portfolio Data

Total Number of Holdings: 30

Number of Bond Holdings: 0

Number of Equity Holdings: 25

Total Market Value: 326,593,372

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Gilead Sciences Inc5.8810282,264-1,32818,287,885

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant35.45
Large22.31
Medium15.23
Small15.40
Micro11.54

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

10.9815

Price/Book*

3.2921

Price/Sales*

2.2995

Price/Cash Flow*

9.3681

Dividend Yield*

1.5169

Growth Measures

Long-Term Earnings

4.7770

Historical Earnings

12.3234

Sales Growth

6.9870

Cash-Flow Growth

13.9303

Book-Value Growth

8.3644

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.